Genetic biomarker test predicts how men with high-risk prostate cancer will respond to treatment

By | October 26, 2021
A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy.